About cancer
Breast cancer
Colorectal cancer
Lung cancer
Renal cell cancer
Clinical cases
Expert reviews
Highlights
Product information
News
Webcasts
Home
Site Map
Avastin®
About Avastin
Avastin® development
Efficacy
Administration
Angiogenesis
Breast cancer
Colorectal cancer
Lung cancer
Renal cell cancer
Herceptin®
Mabthera®
Tarceva®
Xeloda®
Home
/
EN
/
Product information
/
Avastin®
/
About Avastin
/
Avastin® development
Avastin® development
The hallmarks of cancer
Unlimited cell growth
Insensitivity to antigrowth signals
Reduced sensitivity to apoptosis
Functional immortality
Development and maintenance of vasculature (angiogenesis)
Invasion and metastasis
The balance hypothesis for the angiogenic switch
Hanahan, et al. Cell 1996
Page
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
Privacy Policy
|
Legal Statement
The information on this Web site is intended only for visitors from Aruba, Bahamas, Barbados, Bermuda, Curacao, Jamaica, St. Maarten, St. Lucia and Trinidad & Tobago
All rights reserved © 2008 F. Hoffmann-La Roche Ltd.